Citation: | Jia Baoxiang, Lin Jun, Wu Junjie, et al. Relation between donor-recipient HLA mismatching and combined malignant tumor after renal transplantation[J]. ORGAN TRANSPLANTATION, 2014, 5(4): 227-230. doi: 10.3969/j.issn.1674-7445.2014.04.007 |
[1] |
牛斌,林静,陈晓瑜,等.肾移植术后新发恶性肿瘤临床分析[J].器官移植, 2013, 4(2):91-94. http://www.organtranspl.com/browse/detail/qkid/63/id/309.html
Niu B, Lin J, Chen XY, et al. Clinical analysis of de novo malignancies after renal transplantation[J]. Organ Transplant,2013,4(2):91-94. http://www.organtranspl.com/browse/detail/qkid/63/id/309.html
|
[2] |
田普训,薛武军,丁小明,等.影响肾移植受者长期存活的多因素分析——单中心989例经验总结[J].中华器官移植杂志,2012,33(12):706-709. http://cdmd.cnki.com.cn/Article/CDMD-90024-2004136501.htm
Tian PX, Xue WJ, Ding XM, et al. A multifactorial analysis on long-term survival of kidney transplantation recipients: a report of 989 cases in one centre[J]. Chin J Organ Transplant,2012,33(12):706-709. http://cdmd.cnki.com.cn/Article/CDMD-90024-2004136501.htm
|
[3] |
杨庆,肖成武,王林辉,等.肾移植术后自体泌尿系统肿瘤25例临床分析[J].中华器官移植杂志,2012,33(7):397-399.
Yang Q, Xiao CW, Wang LH, et al. Clinical analysis of 25 cases of autologous urological neoplasms in renal transplant recipients[J]. Chin J Organ Transplant, 2012,33(7):397-399.
|
[4] |
Apel H, Walschburger-Zorn K, Häberle L, et al. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr[J]. Clin Transplant,2013,27(1):E30-E36. doi: 10.1111/ctr.2013.27.issue-1
|
[5] |
Yunus M, Aziz T, Mubarak M. Posttransplant malignancies in renal transplant recipients: 22-years experience from a single center in Pakistan[J]. Asian Pac J Cancer Prev,2012,13(2):575-578. doi: 10.7314/APJCP.2012.13.2.575
|
[6] |
Bottomley MJ, Harden PN. Update on the long-term complications of renal transplantation[J]. Br Med Bull,2013,106:117-134. doi: 10.1093/bmb/ldt012
|
[7] |
Rocha A, Malheiro J, Fonseca I, et al. Noncutaneous neoplasms after kidney transplantation: analysis at single center[J]. Transplant Proc,2013,45(3):1102-1105. doi: 10.1016/j.transproceed.2013.02.005
|
[8] |
Hibberd AD, Trevillian PR, Wlodarczyk JH, et al. Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study[J]. Transplantation,2013,95(1):122-127. doi: 10.1097/TP.0b013e3182782f59
|
[9] |
Karczewski M, Czapiewski W, Karczewski J. Urologic de novo malignancies after kidney transplantation: a single center experience[J].Transplant Proc, 2012, 44(5):1293-1297. doi: 10.1016/j.transproceed.2011.11.063
|
[10] |
Ruangkanchanasetr P, Lauhawatana B, Leawseng S, et al. Malignancy in renal transplant recipients: a single-center experience in Thailand[J]. J Med Assoc Thai,2012,95(Suppl 5):S12-S16. http://cn.bing.com/academic/profile?id=142869489&encoded=0&v=paper_preview&mkt=zh-cn
|
[11] |
Hutton B, Joseph L, Yazdi F, et al. Checking whether there is an increased risk of post-transplant lymphoproliferative disorder and other cancers with specific modern immunosuppression regimens in renal transplantation: Protocol for a network meta-analysis of randomized and observational studies[J]. Syst Rev, 2014,3(1):16. doi: 10.1186/2046-4053-3-16
|
[12] |
Serre JE, Michonneau D, Bachy E, et al. Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival[J]. Kidney Int,2014,85(1):182-190. doi: 10.1038/ki.2013.253
|
[13] |
Longmore DK, Conwell LS, Burke JR, et al. Post-transplant lymphoproliferative disorder: no relationship to recombinant human growth hormone use in Australian and New Zealand pediatric kidney transplant recipients[J]. Pediatr Transplant, 2013,17(8):731-736. doi: 10.1111/petr.2013.17.issue-8
|
[14] |
Khedmat H, Taheri S. Ultra-early onset post-transplantation lymphoproliferative disease[J]. Saudi J Kidney Dis Transpl,2013,24(6):1144-1152. doi: 10.4103/1319-2442.121270
|
[15] |
唐睿珠,雷雨,李继梅,等.HLA-A*02等位基因与云南宣威肺癌相关性研究[J].中国免疫学杂志,2010,26(7):624-626,638. http://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ201007012.htm
Tang RZ, Lei Y, Li JM, et al. The study on HLA-A*02 allele frequency and its relationship with the susceptibility to lung cancer in Yunnan Xuanwei[J]. Chin J Immunol,2010,26(7):624-626,638. http://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ201007012.htm
|
[16] |
马斌,郭鑫,高平,等.HLA-DRB1及DQB1等位基因多态性与宁夏回族人群食管癌的关联性研究[J].宁夏医学杂志,2010,32(11):987-989,前插4. http://www.cnki.com.cn/Article/CJFDTOTAL-NXYX201011007.htm
Ma B, Guo X, Gao P, et al. Associative study of polymorphisms of HLA-DRB1 and DQB1 in genetic susceptibility to esophageal cancer in Ningxia Hui ethnic[J]. Ningxia Med J,2010,32(11):987-989, front insert 4. http://www.cnki.com.cn/Article/CJFDTOTAL-NXYX201011007.htm
|
[17] |
彭明强,杨志豪,方自林,等.国内公开报道的肾移植后并发恶性肿瘤病例的总结分析[J].中华器官移植杂志,2005,26(5):269-271. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHQG200505003.htm
Peng MQ, Yang ZH, Fang ZL, et al. An assemble analysis of malignancy following renal transplantation in China[J]. Chin J Organ Transplant,2005,26(5):269-271. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHQG200505003.htm
|